CN Stock MarketDetailed Quotes

000028 China National Accord Medicines Corporation

Watchlist
  • 27.63
  • -0.28-1.00%
Trading Jan 7 09:41 CST
15.38BMarket Cap10.43P/E (TTM)

China National Accord Medicines Corporation Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

China National Accord Medicines Corporation Q3 2024 Earnings Date

Currency：CNYOct 29, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
18.86B
18.68B
-183.63M
Miss Est.
+3.66%
+2.65%
-0.97%
EPS
0.62
0.58
-0.04
Miss Est.
-4.62%
--
-6.45%
Analyst Rating
Strong Buy

Jan 6, 2025

China National Accord Medicines Corporation Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 19.817B--
--2024/Q4-- / 19.766B--
Oct 29, 20242024/Q318.680B / 18.864B--
Aug 29, 20242024/Q218.695B / 21.205B--
--2024/Q119.090B / 19.860B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 19.817B--
--2024/Q4-- / 19.766B--
Oct 29, 20242024/Q318.680B / 18.864B--
Aug 29, 20242024/Q218.695B / 21.205B--
--2024/Q119.090B / 19.860B--

Unlock Free Earnings Estimates

China National Accord Medicines Corporation Earnings Reports

  • Sinopharm is consistent: report for the third quarter of 2024

    Oct 28, 2024 12:00 ET

  • Sinopharm is consistent: quick performance report for the first three quarters of 2024

    Oct 22, 2024 12:00 ET

  • Sinopharm is consistent: summary of the 2024 semi-annual report

    Aug 28, 2024 12:00 ET

  • Sinopharm is consistent: 2024 semi-annual report

    Aug 28, 2024 12:00 ET

    • Read more

    Top CN Stock Gainers
    Symbol Price % Chg
    Hangzhou Huasu Technology
    301157
    58.54 +20.01%
    Zhejiang Chunhui Intelligent Control
    300943
    13.80 +20.00%
    Zhengzhou Tiamaes Technology
    300807
    36.37 +19.99%
    Shenzhen Dvision
    300167
    2.30 +19.79%
    XMRBI
    837748
    21.51 +17.03%

    See the daily top gainer.

    Analysis

    Analyst Rating

    Updated: Jan 6, 2025

    Strong Buy

    • Strong Buy

      90.00%

    • Buy

      10.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data